Client & Alumni News

Ben Franklin Client Saladax Receives $22.4 Million Strategic Equity Investment

Saladax Biomedical, Inc. produces MyCare™, sophisticated blood tests that quickly, accurately, and inexpensively determine systemic chemotherapy drug levels that enable oncologists to personalize dosing for optimal results in cancer patients. The company will utilize the funds from this equity investment to support ongoing clinical development efforts that will lead to the expansion of the MyCare product line, as well as support the commercialization of the company’s current portfolio of MyCare assays. Saladax is located in Ben Franklin TechVentures®. Read More: